MONTEBELLO, N.Y., July 18, 2017 -- Sterling Bancorp (NYSE:STL) today announced that Kroll Bond Rating Agency (KBRA), a full-service rating agency, has initiated coverage on the Company and its Sterling National Bank subsidiary, and has assigned the following investment grade ratings:
| Entity | Type | Rating | Outlook |
| Sterling Bancorp | Senior Unsecured Debt | BBB+ | Stable |
| Subordinated Debt | BBB | Stable | |
| Short-Term Debt | K2 | NA | |
| Sterling National Bank | Deposit | A- | Stable |
| Senior Unsecured Debt | A- | Stable | |
| Subordinated Debt | BBB+ | Stable | |
| Short-Term Deposit | K2 | NA | |
| Short-Term Debt | K2 | NA |
Jack Kopnisky, President and CEO of Sterling Bancorp, stated, “We are pleased with the strong initial rating from Kroll Bond Rating Agency. The investment grade rating recognizes the results of our efforts to build a high-performing regional bank, and should be especially meaningful as our commercial banking teams continue their outreach to institutional and larger commercial clients.”
Commenting on the basis of the ratings, the KBRA Rating Report stated, “Sterling Bancorp’s performance has been solid in recent years, with a core ROA approximating 1.2%, driven by very low credit costs, a competitive NIM (net interest margin) and favorable operating efficiency, the latter, in part, based on the company’s commercially oriented business model. Capital metrics, including a +8% TCE (tangible common equity) ratio, are considered suitable for the assigned ratings.”
About Sterling Bancorp
Sterling Bancorp, whose principal subsidiary is Sterling National Bank, specializes in the delivery of service and solutions to business owners, their families and consumers within the communities it serves through teams of dedicated and experienced relationship managers. Sterling National Bank offers a complete line of commercial, business, and consumer banking products and services. For more information, visit the Sterling Bancorp website at www.sterlingbancorp.com.
Forward-Looking Statements
This release may contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements may concern Sterling's current expectations about its future results, plans, operations and prospects and are subject to numerous assumptions, risks and uncertainties, including inflation; the effects of, and changes in, trade; changes in asset quality and credit risk; introduction, withdrawal, success and timing of business initiatives; capital management activities; customer disintermediation; and the success of Sterling at managing these risks. Other factors that could cause Sterling's actual results to differ from those indicated in forward-looking statements are included in the "Risk Factors" section of Sterling's securities filings with the Securities and Exchange Commission. The forward-looking statements included herein are only made as of the date hereof, and Sterling specifically disclaims any obligation to update these statements in the future.
STERLING BANCORP CONTACT: Luis Massiani, SEVP & Chief Financial Officer 845.369.8040 Sterling Bancorp 400 Rella Boulevard Montebello, NY 10901-4243 T 845.369.8040 F 845.369.8255 http://www.sterlingbancorp.com


Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Italy Fines Apple €98.6 Million Over App Store Dominance
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 



